Phaarmasia P/E Ratio
Current P/E Ratio
3.41
Low Valuation
Very Low - Potentially undervalued or facing challenges
Phaarmasia (PHRMASI) P/E ratio is 3.41 (Low), EPS (TTM) ₹25.74, current price ₹88.00 on BSE — Very Low - Potentially undervalued or facing challenges. For live price, revenue and the complete fundamental profile, see PHRMASI screener.
Current Valuation Metrics
P/E Ratio
3.41
Current Price
₹88.00
EPS (TTM)
₹25.74
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
57.01
Sector Median
32.06
Sector Rank
#4 of 199
Sector Percentile
2.0%
PHRMASI P/E Ratio — Valuation Signal & Historical Context
Phaarmasia P/E 3.41 — signal: Undervalued. Also explore Phaarmasia share price performance to track price trends across different timeframes.
- Stock appears undervalued with PE of 3.41, suggesting potential buying opportunity
- Trading at discount to sector average PE of 57.01
PHRMASI vs Healthcare Peers — P/E Ratio Comparison
Phaarmasia P/E 3.41 vs Healthcare average 57.01, median 32.06 — range 1.99–747.21.
Sector Average
57.01
Sector Median
32.06
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |
| Royal Sense | ROYAL | 7.11 | ₹50 | Low |